Oramed Pharmaceuticals Inc. Logo

Oramed Pharmaceuticals Inc.

ORMP | TA

Overview

Corporate Details

ISIN(s):
US68403P2039
LEI:
Country:
Israel
Address:
20 Mamilla Avenue, 9414904 Jerusalem
Sector:
Health Care
Industry:
Biotechnology

Description

Oramed Pharmaceuticals specializes in developing oral drug delivery systems for injectable therapies, focusing on diabetes treatment in Israel.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-23 17:53
Takeover Announcement Report
Option Agreement for the Repurchase of Warrants
English 316.7 KB
2025-07-23 17:53
Regulatory News Service
Option Agreement for the Repurchase of Warrants
English 36.4 KB
2025-07-18 14:52
Proxy Solicitation & Information Statements
Other Report or Announcement
English 1.4 MB
2025-07-18 14:52
Regulatory News Service
Other Report or Announcement
English 36.4 KB
2025-07-18 14:51
Annual Report
Other Report or Announcement
English 448.1 KB
2025-07-18 14:51
Regulatory News Service
Other Report or Announcement
English 36.4 KB
2025-07-18 14:50
Annual Report
Other Report or Announcement
English 359.9 KB
2025-07-18 14:50
Regulatory News Service
Other Report or Announcement
English 36.4 KB
2025-06-10 11:06
Directors' Dealings
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Reznick Yehuda
English 574.4 KB
2025-06-10 11:06
Foreign Filer Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Reznick Yehuda
English 36.2 KB
2025-05-22 08:30
Transaction in Own Shares
Form 8-K-a one-year extension of the Company’s current stock buyback program
Hebrew (modern) 92.1 KB
2025-05-22 08:30
Transaction in Own Shares
Form 8-K-a one-year extension of the Company’s current stock buyback program
Hebrew (modern) 36.4 KB
2025-05-16 13:29
Quarterly Report
Form 10-Q-For the quarterly period ended March 31, 2025
English 1.1 MB
2025-05-16 13:29
Foreign Filer Report
Form 10-Q-For the quarterly period ended March 31, 2025
English 36.3 KB
2025-04-29 11:13
Takeover Announcement Report
FORM 8-K-entered into purchase agreement of 14,110,121 of Alpha Tau’s ordinary …
English 400.3 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC